Answers are grounded in this paper and cite their sources.
Oral squamous cell carcinoma (OSCC) is a global health burden, particularly in South and Southeast Asia, where betel quid (BQ) chewing remains highly prevalent. As epidemiological evidence consistently identifies BQ as an independent risk factor for OSCC, recent high-throughput sequencing analyses and experimental mutagenesis studies have substantially advanced our understanding of the biological mechanisms underlying BQ-related oral tumorigenesis. This review provides an updated overview of the molecular and cellular alterations associated with chronic BQ exposure during OSCC development, with particular emphasis on genotoxicity, epigenetic and noncoding RNA-mediated remodeling, and immune dysregulation. BQ and its related constituents induce diverse forms of genomic instability in oral tissues, including chromosomal abnormalities, impaired DNA repair, characteristic mutational spectra/signatures, copy-number alterations, and loss of heterozygosity. Concurrently, chronic BQ exposure promotes widespread epigenetic dysregulation through altered DNA methylation, histone modification, and noncoding RNA-mediated pathways, resulting in silencing of tumor suppressor genes and activation of oncogenic signaling. Emerging evidence also suggests that BQ exposure may reshape the immune microenvironment of OSCC into a permissive niche for tumor progression and therapeutic resistance, highlighted by increased infiltration of tumor-associated macrophages, altered immunoregulatory dendritic cell programs, and activation of immune checkpoint pathways such as PD-L1/PD-1 and CD155/TIGIT. Collectively, these findings suggest that BQ-related OSCC may represent an etiologically defined subgroup of oral cancer with partially distinct genomic, epigenetic, and immunologic features, although further validation across anatomical sites, exposure patterns, and population backgrounds is required. A better understanding of these alterations may facilitate the development of novel prognostic biomarkers and precision therapeutic strategies for BQ-related oral cancer.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: